Aceclofenac (NA)+ Paracetamol (NA)+ Chlorzoxazone (NA)
Aldigesic Injection is given by a doctor or a nurse. You should not self-administer this at home. The dose will depend on what you are taking it for and how well it helps your symptoms. You should take it as advised by your doctor. Do not take more or use it for a longer duration than recommended by the doctor.The most common side effects of this medicine include nausea, vomiting, heartburn, stomach pain, diarrhea, and loss of appetite. If any of these side effects bother you or get worse, you should let your doctor know. Your doctor may be able to suggest ways of preventing or reducing the side effects.Before taking it, you should let your doctor know if you have a history of ulcer or bleeding in your stomach, high blood pressure, or have any trouble with your heart, kidneys, or liver. Let your doctor also know about all the other medicines you are taking because they may affect, or be affected by, this medicine. Pregnant or breastfeeding women should consult their doctor before starting treatment.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Aldigesic
1 ml Injection
Alkem Laboratories Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Aldigesic Injection is a combination of two pain relieving medicines (Aceclofenac and Paracetamol) and a muscle relaxant (Chlorzoxazone). The pain relieving medicines work by blocking the release of certain chemical messengers in the brain that cause pain and inflammation (redness and swelling). The muscle relaxant works on the centers in the brain and spinal cord to relieve muscle stiffness or spasm, thereby improving muscle movement.
Related Warnings
It is not known whether it is safe to consume alcohol with Aldigesic Injection. Please consult your doctor.
Information regarding the use of Aldigesic Injection during pregnancy is not available. Please consult your doctor.
Information regarding the use of Aldigesic Injection during breastfeeding is not available. Please consult your doctor.
It is not known whether Aldigesic Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
There is limited information available on the use of Aldigesic Injection in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Aldigesic Injection in patients with liver disease. Please consult your doctor.
Aldigesic Injection is a combination of three medicines: Aceclofenac, Paracetamol and Chlorzoxazone. This medicine helps in relieving muscle pain by relaxing the affected muscles. It relieves pain caused due to muscle spasm, cramp or injury. It also lowers certain chemical substances in the body that cause pain.
If you are suffering from muscle pain due to muscle injury or overuse, you should take rest. Taking rest will help you avoid any further injury and help you recover efficiently. Make sure that you take plenty of sleep and try to reduce stress. Applying ice pack to the affected area may help in relieving pain and inflammation. If your muscle pain is due to some other disease, follow the advice of your doctor.
No, there are no reports of any patient getting addicted to Aldigesic Injection.
Aldigesic Injection is usually used for short term and can be discontinued when your pain is relieved. However, Aldigesic Injection should be continued if you are advised by your doctor to do so.
Yes, the use of Aldigesic Injection can cause dizziness (feeling faint, weak, unsteady or lightheaded) in some patients. If you feel dizzy or lightheaded, it is better to rest for some time and resume once you feel better.
Aldigesic Injection contains Paracetamol and Chlorzoxazone, both these medicines are known to cause harm to the liver especially when taken in doses above the recommended level. Also, avoid drinking alcohol while taking this medicine, as it may further increase your risk of liver damage. Use of this medicine should preferably be avoided in patients with underlying liver disease. Contact your doctor immediately if you notice any early signs and symptoms of liver damage. These symptoms may include fever, rash, loss of appetite, nausea, vomiting, fatigue, stomach pain, dark urine, yellow skin or eyes and abnormal live enzymes.
It may take about an hour to notice the initial benefits of pain relief after taking Aldigesic Injection.
If you forget to take the scheduled dose of Aldigesic Injection and it is almost time for your next dose, skip the dose you missed and take your next dose at the scheduled time. Otherwise, take it as soon as you remember, and then go back to taking your medicine as you would normally. Do not take a double dose to make up for the dose you missed because this may increase the risk of unwanted side effect due to overdosage. If you are not sure what to do, consult your doctor about how to manage a situation like this.
No, taking a higher than the recommended dose may not be more effective, rather it may increase the chances of having some serious side effects and toxicity. If you experience increased severity of your symptoms that are not relieved by the recommended doses, please consult your doctor for re-evaluation.
The use of Aldigesic Injection is considered to be harmful in patients with known allergy to any of the components or excipients of this medicine. The use of this medicine should preferably be avoided in patients with a history of stomach ulcers or active, recurrent stomach ulcer / bleeding. It should also be avoided in patients with a history of heart failure, high blood pressure, and liver or kidney disease.
Yes, Aldigesic Injection does expire. Please check the expiry date written on the pack of this medicine. Do not use Aldigesic Injection after the expiry date.
